S. 4363In committeeGovernment & democracy
Senate bill targets engineered biology in biodefense reports
Data as of July 11, 2026
This bill extends deadlines for biodefense briefings and requires a new government report on the risks of engineered biology.45-second read · 4 questions answered below
Decoded
What does this do?
This bill pushes back the deadline for yearly government briefings to Congress on the national biodefense strategy. It also requires the next routine government report on biological threats to include a deep analysis of risks from engineering biology, such as gene-editing and synthetic biology, plus recommendations for new laws, programs, cost estimates, and ways to support responsible science while preventing misuse.
Who does it affect?
This bill affects federal agencies working in national security, public health, and biodefense. It also affects researchers and companies in the life sciences, and Congress, which would receive and act on the findings.
Why does it matter?
Congress would receive more detailed information about biological risks tied to engineered organisms and where current rules may fall short. Federal agencies could face new guidance about how to reduce overlapping or conflicting efforts in this area.
Where does it stand?
- Introduced
- Senate committee — You are here
- Senate vote
- House
- President's desk
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
AI-drafted summary. Verify it against the official text before you act on it.
Three steps: where you stand, your script, the call.
Make the callSee how a call works
Official title
Engineering Biology Readiness Act
- Introduced:
- April 21, 2026
- Latest action:
- April 21, 2026
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Read the official bill on Congress.govMake the call
Three steps: where you stand, your script, the call.